BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26207746)

  • 1. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1).
    Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
    J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity.
    Yang SM; Martinez NJ; Yasgar A; Danchik C; Johansson C; Wang Y; Baljinnyam B; Wang AQ; Xu X; Shah P; Cheff D; Wang XS; Roth J; Lal-Nag M; Dunford JE; Oppermann U; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
    J Med Chem; 2018 Jun; 61(11):4883-4903. PubMed ID: 29767973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
    Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C
    Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.
    Li B; Yang K; Liang D; Jiang C; Ma Z
    Eur J Med Chem; 2021 Jan; 209():112940. PubMed ID: 33328099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
    Morgan CA; Hurley TD
    Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity.
    Liang D; Fan Y; Yang Z; Zhang Z; Liu M; Liu L; Jiang C
    Eur J Med Chem; 2020 Feb; 187():111923. PubMed ID: 31816557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
    Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.
    Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA
    Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
    Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
    Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.
    Buchman CD; Hurley TD
    J Med Chem; 2017 Mar; 60(6):2439-2455. PubMed ID: 28219011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.
    Koppaka V; Thompson DC; Chen Y; Ellermann M; Nicolaou KC; Juvonen RO; Petersen D; Deitrich RA; Hurley TD; Vasiliou V
    Pharmacol Rev; 2012 Jul; 64(3):520-39. PubMed ID: 22544865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
    Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
    Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
    Chen Y; Orlicky DJ; Matsumoto A; Singh S; Thompson DC; Vasiliou V
    Biochem Biophys Res Commun; 2011 Feb; 405(2):173-9. PubMed ID: 21216231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis of 1,3-dimethylpyrimidine-2,4-diones as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
    Ma Z; Jiang L; Li G; Liang D; Li L; Liu L; Jiang C
    Bioorg Chem; 2020 Aug; 101():103971. PubMed ID: 32480173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
    Morgan CA; Hurley TD
    J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.
    Khanna M; Chen CH; Kimble-Hill A; Parajuli B; Perez-Miller S; Baskaran S; Kim J; Dria K; Vasiliou V; Mochly-Rosen D; Hurley TD
    J Biol Chem; 2011 Dec; 286(50):43486-94. PubMed ID: 22021038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the Structural Requirements of Theophylline-Based Aldehyde Dehydrogenase lAl (ALDHlAl) Inhibitors Through Multi-QSAR Modeling and Molecular Docking Approaches.
    Abdul Amin S; Adhikari N; Gayen S; Jha T
    Curr Drug Discov Technol; 2016; 13(2):84-100. PubMed ID: 27132720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
    Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ
    Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
    Huddle BC; Grimley E; Buchman CD; Chtcherbinine M; Debnath B; Mehta P; Yang K; Morgan CA; Li S; Felton J; Sun D; Mehta G; Neamati N; Buckanovich RJ; Hurley TD; Larsen SD
    J Med Chem; 2018 Oct; 61(19):8754-8773. PubMed ID: 30221940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity.
    Yasgar A; Titus SA; Wang Y; Danchik C; Yang SM; Vasiliou V; Jadhav A; Maloney DJ; Simeonov A; Martinez NJ
    PLoS One; 2017; 12(1):e0170937. PubMed ID: 28129349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.